Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancerMohamed El‐Tanani, Philip S. Rudland, Khaled Abdul‐Aziz Ahmed et al.|Life Sciences|2023Cited by 8
Corrigendum to “Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer” [Life Sci., 329 (2023) 121964]Mohamed El‐Tanani, Philip S. Rudland, Angela Platt‐Higgins et al.|Life Sciences|2023Cited by 1